|

Metacognitive Therapy Compared to Cognitive-behavioral Therapy

RECRUITINGN/ASponsored by Karolinska Institutet
Actively Recruiting
PhaseN/A
SponsorKarolinska Institutet
Started2026-01-28
Est. completion2026-12
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

This is a qualitative study of participants who have taken part in a randomized controlled trial comparing transdiagnostic metacognitive therapy and disorder-specific cognitive-behavioral therapy for anxiety disorders. The purpose of the study is to explore participant perceptions of the respective treatment models to facilitate implementation and dissemination of the treatments.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age 18 years or older,
* A principal diagnosis of generalized anxiety disorder, social anxiety disorder, or posttraumatic stress disorder,
* No change in dose during the last six weeks if on pharmacological treatment, and
* Ability to read and speak Swedish.

Exclusion Criteria:

* A current diagnosis of psychotic disorder, bipolar disorder, neurocognitive disorder, or moderate to severe substance use disorder,
* Acute suicide risk, or
* Concurrent psychological treatment.

Conditions4

AnxietyGeneralized Anxiety DisorderPosttraumatic Stress Disorder (PTSD)Social Anxiety Disorder

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.